UK markets close in 5 hours 35 minutes
  • FTSE 100

    7,403.03
    -91.10 (-1.22%)
     
  • FTSE 250

    21,700.18
    -563.06 (-2.53%)
     
  • AIM

    1,102.89
    -29.19 (-2.58%)
     
  • GBP/EUR

    1.1921
    -0.0026 (-0.22%)
     
  • GBP/USD

    1.3499
    -0.0047 (-0.35%)
     
  • BTC-GBP

    24,864.85
    -1,803.84 (-6.76%)
     
  • CMC Crypto 200

    765.22
    +522.55 (+215.32%)
     
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • DOW

    34,265.37
    -450.03 (-1.30%)
     
  • CRUDE OIL

    84.77
    -0.37 (-0.43%)
     
  • GOLD FUTURES

    1,838.40
    +6.60 (+0.36%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • HANG SENG

    24,656.46
    -309.09 (-1.24%)
     
  • DAX

    15,309.42
    -294.46 (-1.89%)
     
  • CAC 40

    6,940.05
    -128.54 (-1.82%)
     

Women’s Health Market Report Up to 2031: Visiongain Research Inc

·4-min read

Visiongain has published a new report on Women’s Health Market Report 2021-2031: Forecasts by Application (Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, PCOS). PLUS, Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/womens-health-market-2021/#download_sampe_div

Women’s are on higher threat of getting infected with diseases such as osteoporosis, osteoarthritis, anaemia, menstrual health related disorders, depression and obesity. An upsurge in the population over 60 age, a rise in adoption of sedentary lifestyle habits, and the introduction of novel medicines for women are some of the factors that drive market growth.

COVID-19 Impact on Women’s Health Market

In this period of COVID 19 pandemic, an awareness towards the health care is likely to increase among the people. Especially towards the women’s healthcare. Because women’s play an important role in an individual’s life. Moreover, women’s have complicated issues regarding their health. Many programmes are running by various organisations regarding women’s care. In short COVID 19 pandemic is stimulating this market indirectly toward growth.

Market Drivers

Changes in dietary habits, stress, and consumption of alcohol are the key factors responsible for hormonal imbalance among women. This is likely to cause fertility issues in women. Ovulation problems, endometriosis and polycystic ovarian syndrome are the major known factors for infertility. And these factors direct the Women’s Health Market towards growth.

Market Opportunities

The hormonal infertility sector is expected to grow rapidly owing to high fertility associated problems in developed countries. And the easy availability of several medicines to cure hormonal imbalance and market players’ investment in new product development would drive this segment towards growth. Hormonal imbalance such as the imbalance of prolactin, estrogen, and thyroid is increasing in women due to factors such as stress, further driving the demand for medication to improve health. In turn this segment is proving as a substantial growth opportunity for the Women’s Health Market towards growth.

Get Detailed TOC @ https://www.visiongain.com/report/womens-health-market-2021/#download_sampe_div

Competitive Landscape

Some of the key players functioning in the market are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb; and Ferring B.V. Partnerships for product development, enlargement of product portfolios, and geographical expansion in developing markets are the significant strategic endeavors of these companies to upsurge their market share.

Market player’s emphasis on gaining FDA approval for new disease symptoms to in order to prevent loss in revenues post-patent expiry. For instance, Prolia is suggested for postmenopausal women who are vulnerable to bone fractures due to osteoporosis. The symptoms differ according to the approvals across various geographies. In U.S. for instance, it is mainly used as a second or third level of treatment for women who have suffered at least one or multiple osteoporotic fractures. In Europe, it is recommended for women with a high threat of osteoporotic fractures and as a treatment of osteoporosis.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email contactus@visiongain.com

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Women’s health market and leading companies. You will find data, trends and predictions.

Find more Visiongain research reports on Therapeutic Drugs Sector click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter

-

SOURCE Visiongain Limited.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting